Retail

e.l.f. Beauty Beats Q3, Raises Full-Year Guidance

e.l.f. Beauty beat expectations in Q3 2026, delivering adjusted EPS of $1.24 on revenue of $489.5 million and lifting its full-year outlook. The quarter centered on the completed Rhode acquisition, which contributed to net sales growth and offered a path to stronger international expansion.

e.l.f. Beauty Beats Q3, Raises Full-Year Guidance

Key Takeaways

  • Q3 adjusted EPS of $1.24, above consensus
  • Q3 net sales of $489.5 million, up 38% year over year
  • Rhode acquisition completed for roughly $1 billion
  • Rhode contributed $128 million to Q3 net sales growth
  • 130 basis points of market-share gains for e.l.f. Cosmetics

People Involved

  • Tarang AminCEO, e.l.f. Beauty
  • Hailey BieberFounder, Rhode

Entities Involved

  • e.l.f. Beauty, Inc. (ELF)Cosmetics company
  • RhodeHailey Bieber skincare brand

MarketMoodz Analysis

Investors are seeing a beat-and-raise narrative emerge as e.l.f. expands its product mix beyond cosmetics into prestige skincare via Rhode. The contribution from Rhode—both as a completed acquisition and as a sales driver—could support margin expansion through higher-margin product mix and broader distribution, while validating e.l.f.'s marketing engine and omnichannel reach. The 38% top-line growth and 130 basis-point market-share gain point to meaningful execution on the integration thesis.

Longer-range, the Rhode deal adds a growth lever for a small-cap beauty incumbent, potentially supporting multiple expansion if the trajectory persists. Still, the risks are non-trivial: raw-material costs, foreign-exchange headwinds, and promotional spend could pressure margins as the company scales. Investors should watch Rhode's contribution to gross margins, the pace of international distribution, and any updates to the full-year outlook, particularly the implied uplift from the earlier guidance.

Get AI-Powered Market Insights

Stay ahead of market-moving events with our real-time analysis and stock ratings.

Start Your Free Trial